Skip to main content
Achieving Health podcast series wave graphic.

What the Election Means for Healthcare: Beth Feldpush, AEH

Tune in to learn how Congress may approach affordability, Medicaid cuts, and other policy issues.

In this episode of the “Achieving Health” podcast, Beth Feldpush, senior vice president of advocacy and policy at America’s Essential Hospitals, joins hosts Chad Mulvany and Shawn Stack to discuss what the results of the 2026 midterm election could mean for healthcare policy and legislation. They also explore how this could affect healthcare organizations and the communities they serve.

Beth shares her thoughts on:

  • How the new Congress may address healthcare affordability, Medicaid cuts, insurance coverage, 340B, and other key policy issues
  • Healthcare policies that could advance through bipartisan legislation, and those that may face obstacles to becoming law
  • How healthcare executives can effectively communicate with policymakers about the financial and operational realities they’re facing

Transcript

CHAD MULVANY

On today’s episode of “Achieving Health,” we’ll be joined by special guest Beth Feldpush, Senior Vice President of Advocacy and Policy at America’s Essential Hospitals. We’ll discuss what the recent election results mean for healthcare organizations, including potential legislation and policies to watch for. Stay tuned.

ANNOUNCER

This is “Achieving Health,” a podcast from Forvis Mazars, where we delve into the topics that matter most to healthcare organizations across the continuum of care. Our goal is to help you navigate the dynamic healthcare landscape and achieve health at your organization.

CHAD MULVANY

Welcome to Achieving Health. I’m Chad Mulvany.

SHAWN STACK

And I’m Shawn Stack. Thank you for joining us.

CHAD MULVANY

For today’s episode we have a special guest, Beth Feldpush. Beth is the Senior Vice President of Policy and Advocacy at America’s Essential Hospitals and she’s just a wealth of knowledge about the laws and policies that affect hospitals and communities they serve.

Now that the dust has settled on the 2026 midterms, we wanted to invite her on to help unpack what all of this could mean for healthcare and what leaders should be looking for over the next couple of years. Beth, welcome to the podcast and thank you for joining us. We’re really looking forward to this conversation.

I think maybe we should start off with, at the highest level, how did the election results reshape federal healthcare policy or the federal healthcare policy environment for hospitals and health systems? And what should healthcare leaders expect from Congress and the administration over the next two years?

BETH FELDPUSH

Well, thank you, Chad. Thank you, Shawn. Delighted to be here and speak with you today. I think, you know, the election results were surprising, right, to just about everybody who was watching them. I think everybody assumed Democrats had some momentum going into the election, but nobody anticipated the level of seats that they would win in both the House and with switching the Senate over to Democratic control.

So, there’s definitely going to be a shift from Congress in where the focus is and where the priorities are in the next Congress. We know that Democrats are going to be looking at priorities to roll back the Medicaid cuts that were in H.R. 1, but I think it’s important for healthcare leaders to remember that this is not going to be a switch that is quick to flip.

It is going to take them some time to write new legislation, have hearings, figure out exactly what direction they want to go in, figure out how to pay for that. And at the end of the day, if Democrats do move legislation that is favorable to healthcare and favorable to patients, we need to remember that President Trump is still in the White House.

So, whatever Democrats pass still may get vetoed when it gets to the president to sign. So, I think there’s good reasons to be optimistic that some of those cuts will be potentially rolled back. But healthcare leaders need to understand that it’s not going to happen January 1, you know, January 31. It’s likely going to take much of the year.

And so, as someone running a provider or an institution, I would still plan for austere times in 2027, probably still having some patients that lose coverage from Medicaid or other sources. And it’s going to be tight, I think, to start the year, even with that change in the election results.

CHAD MULVANY

Yeah. No, Beth, I completely agree with you. And, you know, I think cautious optimism is the right way to frame it. And certainly the environment is more favorable than two weeks before the election, I was thinking 52 seats in the Senate might have been the best-case scenario for the Democrats.

You still have to, in the Senate, pick up--and this is recording on November 12--so, you still, depending on how Alaska lands, need to pick up either four or five seats in the Senate just to get something through cloture. And then you’re right, you’re still not going to have 66 votes to override a presidential veto if President Trump decides he doesn’t want to sign the legislation.

SHAWN STACK

Yeah, Beth, I think I agree with Chad and your input there on where Democrats are going in the new year with the new Congress. And I think also the pressure is going to build, right, in those first six months of OB3 cuts in Medicaid, those significant cuts. And we’ll see more pressure, right, to do something at the state levels, maybe even from governors weighing in there.

But before that happens, you know, with limited legislative windows before the new Congress convenes, are there certain healthcare issues that you’re watching closely and what’s most likely to move during lame duck, if anything, and where can hospital advocacy have the greatest impact there?

BETH FELDPUSH

Yeah. I think we need to remember, Shawn, right, as you pointed out, that before we get to the 120th Congress, we need to finish the 119th.

SHAWN STACK

Yeah.

BETH FELDPUSH

You know, I think Congress is just coming back into town after a long break leading up to and into the elections. So, I know there’s still a lot of kind of formulation happening about what they do want to focus on.

Republicans are still in charge through the end of this year, through the end of this Congress. The biggest thing they need to do is extend government funding. And so, that is likely to be the focus. What we’re hearing now is that it’s likely to be kind of the only focus or the main focus. I don’t think we’re going to see a lot of healthcare items.

I don’t think we’re going to see a lot of non-healthcare issues either, moving between now and the end of the year. So, Congress is likely to be focused on, you know, just getting the government funded into 2027. And then they’ll be regrouping next year to determine kind of where the priorities are that they go to next. So, probably not a lot between now and December 31.

SHAWN STACK

Okay. Makes sense.

CHAD MULVANY

Yeah. And the other nice thing about it, Beth, is, you know, with the CAA of ‘26, all of the extenders that usually would have expired on a fed fiscal got kicked to December 31, or many of them, or punted into the next year. So, really the deadline that everybody needs to be watching for, like community health center funding or Medicare dependent hospital or low-volume status is really 12/31.

So, as long as they can get either a CR past that puts us into the next Congress or an appropriations bill passed that includes those things, you know, it should be relatively uneventful for providers fingers crossed. The only one that I look at and think, you know, we need to do something about it is a physician fee schedule patch. And that’s the only one where I’m not, you know, reasonably certain that that’ll get done. But my guess is that still might get taken care of as well, just given concerns about what happened in the physician fee schedule final rule.

BETH FELDPUSH

We were in a lucky position in this end of Congress compared to others, or even just kind of other end-of-year times in that, by and large, except for the three items you flag, Chad, on Medicare-dependent hospitals, low-volume adjustment, and the community health centers, well, I guess and physician fee schedules, but most of our main hospital issues are not expiring in any shape or form, kind of at the end of this year, right?

We’ve got telehealth extended for a while. We’ve got hospital at home. Medicaid DSH cuts aren’t a concern right now. So, it is going to be kind of, you know, relatively quiet in terms of key hospital priorities that must be addressed before the end of this Congress.

CHAD MULVANY

You know, Beth, I think you’re right, but I fear you may have just jinxed the holiday season for all of us. But I appreciate you saying it out loud. You know, as we--and Shawn, thank you for sort of pulling us back and making us think about the 119th before we get into the 120th--but looking ahead to the new Congress, where do you see genuine opportunities for bipartisan healthcare legislation? And then, conversely, which issues are more likely to remain stalled or become leveraged in larger negotiations?

BETH FELDPUSH

I think we’re going to see some of the same issues of focus in a Democratic-led Congress that we saw in a Republican-led Congress, but with different messaging and terminology attached to them. So, where Republicans messaged on fraud, waste and abuse, right, which ultimately comes down to taking money out of the system.

I think Democrats are going to focus on that as well, with the framing around affordability. And that mostly means affordability to consumers and affordability to patients, not necessarily affordability to hospitals and providers, which I think we’ll talk about in a few minutes. So, I would expect there to be some areas of bipartisan agreement around making healthcare less expensive for consumers and for patients. And so, I think that’s one area where we’ll continue to see engagement from both sides of the aisle, maybe more engagement across the aisle than we saw this last time.

I’m also hopeful that there’s going to be momentum behind reforms to Medicare Advantage. We know that lawmakers on both sides of the aisle are concerned about issues around prompt pay or lack of it and prior authorization usage. So, that’s another area where I think we’d see both Democratic and Republican lawmakers working together on some legislation in 2027.

SHAWN STACK

From your lips to Congress’ ears, Beth. That’s been a struggle for so many years, right? Especially with delays in utilization management and denials. I mean, those are just hot topics.

BETH FELDPUSH

Yeah, and I think that’s where if you kind of extend that affordability conversation into, you know, power to the people, power to the patients, I think that’s where we kind of see an extension of, you know, from both sides is the populist approach that President Trump takes, as well as kind of this rise in Democrats saying they’re now representing what Americans really want, is this how can we--we, the average American--sort of fight that system? And I think that’s where, you know, we see health insurers and their onerous administrative requirements being an area where lawmakers may focus to say, let’s reclaim some of this power of people to get their healthcare without having to jump through all these paperwork hoops, even though it’s usually the providers in the hospitals that are jumping through the paperwork hoops. But, you know, notwithstanding.

CHAD MULVANY

But it is, you know, with the prior auth in particular, it is an access issue. So, you know, I do think there is reasonable momentum there. And, Beth, I think that populist framing is probably right, because that’s a place where you could see Republicans and Democrats who normally wouldn’t have much in common, come together under common cause.

And certainly, you know, and this could potentially cut both ways. It seems there is this narrative in D.C. that big corporate enterprises in healthcare are driving some of these affordability issues. So, therefore they’re going to start to look at those big corporate entities within a different light.

SHAWN STACK

Yeah, I agree. I mean, we’re talking about affordability here. But this administration and this Congress has seemed to, through payment regulation and legislative action, try to control a lot of healthcare spending, you know, by reducing hospital and provider and physician reimbursement, or at least shifting costs elsewhere in the health system, doing more to migrate inpatient care to outpatient care, which we all know is needed in some situations.

But what meaningful changes, Beth, do you see Congress potentially taking in the new year to really get to healthcare cost for employers, for consumers? And what do you see moving there in a new way?

BETH FELDPUSH

Yeah, I mean, I think I’m not sure--I don’t want to get hung up on the last thing you said, Shawn, about a new way--but I’ll say, you know, the cynic in me kind of says there’s really no, very few new ideas in healthcare policy, right? We tend to recycle the same things over and over again. So, maybe that’s my answer is, you know, I think we’re going to see continuation of those issues on maybe driving down drug prices for consumers.

Again, looking at, you know, the administrative costs from health insurance plans, I think Congress might look at site-neutral payment cuts again as a cost saver, which is really just a cut to hospitals in lowering hospital payments to what physician offices receive. So, I think, you know, I think they’re going to look they’re going to look there.

And then I think where a big fight is going to be is going to be over those Medicaid cuts that we’re passed into law in H.R. 1. And the Republicans frame those as savings to get rid of fraud, waste, and abuse, not trying to take any access away from individuals, but really just kind of weeding out patients who shouldn’t have that coverage or where we’re spending too much money that’s not getting return on investment. We know that Democrats are going to try to push back against those cuts that are already into law, but I think there will be some resistance there, and that we’re going to see that being an area of contention.

CHAD MULVANY

And, you know, Beth, particularly one of the areas that I’m concerned most about is the, in my opinion, erroneous framing that state-directed payments going up to ACR, which has been put forth by HHS, are driving issues with affordability in the commercial sector. Like, that just doesn’t make sense on its face, in my mind. But to me, that feels like where if a Republican didn’t want to, or someone didn’t want to vote to repeal those cuts, that might be the argument that they try to hang their hat on. And so, that one, that one keeps me up at night a little bit.

BETH FELDPUSH

Yes. Completely agree. I think some of these Medicaid financing arrangements that have been in place for decades, you know, some of them since the inception of the Medicaid program, are going to continue to be a target by not only Republicans in Congress, but also the administration.

CHAD MULVANY

You know, when you think about essential and safety net hospitals, which are already under pressure--and we’ve kind of alluded to this in a couple of different places--where do you think there are opportunities to improve affordability without jeopardizing access to essential services like trauma, specialty care, NICUs, etc., that those hospitals provide?

BETH FELDPUSH

Yeah, it’s always a challenge because those hospitals that have the tightest financial pressures are often least able to invest in systems or tools that can help drive down administrative costs. As we’ve talked to our member hospitals, I think a lot of folks are looking first in their back office, central office administrative functions. You know, many of my members say the last thing they want to do is touch patient care and patient access, right? So, they’re looking, they’re looking within their own offices and making sure that, at least from that administrative side themselves, they’re being as efficient as possible.

SHAWN STACK

Beth, do you think that’s challenging for them as payors are doing more to make administrative burden more complex through denials and prior authorizations?

BETH FELDPUSH

It is challenging, and I’m hopeful that the spread of tools and AI can assist with some of those, particularly revenue cycle functions. That’s kind of what I mean by, you know, hospitals that are least able to invest in new tools, right, could use them the most. But I’m hoping that, you know, as the AI industry matures--because it will, we are still very early on with a lot of products flooding the market and trying to figure out what’s best in class to help with things--

I am hopeful that the price of those will start to come down a little bit. And, you know, we’ve got some ideas in the works for how to help our members in evaluating AI technology. And then the other thing I would say, which again, takes an investment, but really digging into your patient navigators and those folks on your team that help connect your patients to the coverage that they’re eligible for, particularly when we see those Medicaid community engagement requirements go into effect, which I think are going to go into effect January 1.

I don’t think there’s any scenario with this Congress where those are stopped before January 1, so, I think that’s going to start. You know, making sure that you’re helping your patients get access to the coverage that they have helps hospitals’ bottom line. Helps the patients, helps the hospital. It’s a win-win. But again, that takes some focus on hospital resources as well.

SHAWN STACK

So, flipping gears here a little bit, how do you think the election results kind of reshape 340B policy landscapes and kind of including that rebate model, claims reporting, contract pharmacy protections, transparency requirements and kind of those prospects to broaden legislative reform?

BETH FELDPUSH

When we’ve looked at the 340B program and you think about congressional action, which is really congressional inaction, right, over the last 15 years or so, there’s always a tension. It is an incredibly difficult program to make policy around for several reasons. One, there’s very few, very little government dollars involved. The discounts flow from pharmaceutical manufacturers to safety net hospitals.

So, you’ve got two very large, substantial healthcare industries that are very much kind of fighting back and forth on this. With the exception of a few staff at HRSA, not a lot of government dollars going into place. So, it is not one that a lot of lawmakers want to take on, because there’s, again, not a lot of skin in the game from the government funding angle, but a whole lot of trouble stirring up healthcare industries.

So, no matter with Democrats in charge of Congress or Republicans in charge of Congress, it’s always a hard issue for Congress to sort of thread the needle on and figure out how they move forward. And the challenge with the fact that Congress has not moved on 340B has meant that pharmaceutical manufacturers who are giving up money, giving up profits on this program, they are taking their action and their advocacy outside of that legislative space.

So, we have seen pharmaceutical manufacturers, you mentioned kind of the rebate program that started with them, pressures on contract pharmacy, looking at changing patient definition. They are making those changes unilaterally and then it’s being fought out in litigation and through the court system. And the courts are never an efficient way to legislate or make policy or anything. So, I don’t know if I really see too much of that tension changing in the next Congress, because all of the players involved are still stuck and dug in to their respective positions.

The one exception to that being, we have seen the administration come out with several anti-340B policies. The big one is those changes in reimbursement on the Medicare outpatient side--so, cuts to 340B hospitals there--and then moving forward with that rebate policy program pilot. So, you know that is likely to move forward and will become part of the debate.

But I don’t really see too much changing on the Hill other than kind of, you know, continued discussion. We think Congress will continue to work on some compromise bills. Where those go at this point is still, I think, a big question.

CHAD MULVANY

You know, Beth, that’s incredibly insightful on where you think 340B is going to go on the Hill. And, you know, I think that’s right. The other thing to add is--and this is my perception--it feels to me like covered entities have had more success in state capitals getting legislation passed at the state level. So, you know, be it contract pharmacy dispense, you’ve had a couple of states now take up the issue of data submission. So, generally good progress. But what we’re starting to see is a federal program that is starting to take on very unique state flavors, almost like sort of a second Medicaid, if you will.

BETH FELDPUSH

Yes, absolutely. The action is moving at the state level, which, you know, I think that’s promising that a number of states have tried to push back against those illegal and onerous pharmaceutical manufacturer actions. But from a national perspective, it’s certainly always more confusing when there’s a patchwork of laws.

CHAD MULVANY

So, we’ve spent a lot of time focusing on Congress and the Hill but significant healthcare policy can also move, and does also move, administratively. Where do you see the greatest potential for consequential healthcare policy changes through CMS and HHS without new legislation? And what’s kind of on your punch list of things that you’re watching for?

BETH FELDPUSH

I think the administration’s going to continue to be very active, and possibly even more so if they don’t have Republicans or when they don’t have Republicans leading the House and the Senate. Where the administration can still influence policymaking is through the executive orders and regulations that they push out. We have already seen them move farther than the statutory language with respect to the Medicaid cuts and other Medicaid provisions that are going into effect.

So, I would anticipate that this administration continues to be aggressive in the regulatory and executive order space. Where those issues are exactly, you know, I think Medicaid is going to continue to be an area of focus. The administration has a lot of authority over approving various state waivers and other Medicaid plans and so, I think they’re going to be very active in those discussions and approving things they like, sending back and refusing things they don’t like. I think they’re going to be very active there.

I also think they’re going to continue to be active in the fraud, waste, and abuse arena as well. They have recently pushed out a proposed regulation kind of looking at how to address fraud in the system. And I think there’s some good things that can come out of that regulation, the acronym is the CARE rule. But I would not be surprised to see them, you know, taking action and enforcement action against states, and providers in those states where they feel that, you know, states are moving in a direction that they’re not aligned with.

SHAWN STACK

I guess, finally, as hospitals and health system leaders look ahead, what should they be doing to strengthen their advocacy efforts in this time of Congress shifting and we see a new legislative forefront, and what do policymakers most need to understand about the financial and operational realities facing providers, and how can healthcare leaders really ensure those realities are reflected in future policy decisions?

BETH FELDPUSH

So, we have a record number of new members of Congress coming in the 120th, which is really a great opportunity to educate all those new lawmakers about what you are doing in your communities, the vital services you’re providing, the challenges of running a highly complex, regulated business where you’re also getting pressure from these third-party payers in the plans.

You know, you’re getting squeezed from all sides. And so, I really hope that hospitals and their leadership, with all of the other challenges that we’ve already talked about that you have facing you, day-in and day-out, but can take the time to reach out to those members of Congress, particularly the new ones. Share your stories with them. Let them see some of the data that you have, showing you the pressures that you’re under, the amount of uncompensated care, the number of days it takes to get reimbursed, the number of prior authorizations. Sharing that story with them, inviting them into your world.

And even better, if you can invite them literally into your hospital so they can kind of see boots on the ground what you’re dealing with, that is incredibly powerful. I know I have kept in touch with some congressional staffers that 15, 20 years ago we would take to visit a hospital. We would take 5 or 6 staffers and just kind of let them spend a morning at a hospital. That was a very powerful experience. And those staffers still talk about that all these years later.

So, really invite them in and let your members of Congress know that you are there for them. If they have a question, if they’re wondering about how a policy would impact you, pick up the phone, call you, ask you, and really let them know that you’re there as a resource.

The final thing I would say is if there’s to any extent you can, particularly with these new Democratic members of Congress, share the patient voice with them. If you have any patients who are really well spoken on what your hospital has done for them, or a family member are also really good spokespeople. That patient voice is, let’s be honest, the most powerful out of all of us.

SHAWN STACK

Yeah. Patient or community access to care voices, right?

CHAD MULVANY

And, you know, Beth, I think your call out to education in general, but particularly new members is incredibly important and incredibly insightful. You know, we all walk around with decades of now knowledge of having worked in the industry and we just sort of assume people know these things. But many of these incoming members, most of these incoming members, don’t have a background in healthcare. They know it’s complicated. And there’s also a lot of misinformation out there about some of the things that health systems do. And so, helping to get ahead of that, I think, would be incredibly helpful.

And the other piece, also, you know, your call out about services is spot on, specifically those services that are losing money but are needed by the community and you’re the only person in the community that might be providing those services. And so, it’s kind of, to your point, connecting it back to patient access.

BETH FELDPUSH

Yeah, I think that’s a great point on the end there, Chad, about, you know, how vital and critical some of these services are. I know for our members that serve that safety net role and provide those high-intensity services, you know trauma care, burn care, they have neonatal intensive care units. There’s nobody else that that can do that.

And I think that’s something that we’ve messaged a lot with Republican lawmakers is sort of understanding that, the free markets great. Capitalism is awesome. But there are some places in society where it just doesn’t work. And that’s where we have public utility and things like that. And so, for some of these services, you know, when you’re running a trauma center, whether you’ve got 10 patients or zero patients on a particular shift, you have to be fully staffed, right? Those are sunk costs. And hospitals are going to continue to provide those critical services because that’s what they do. They are there for their communities.

And so, I think really trying to explain, you know, some of this is where markets break down. Nobody’s fighting to care for a bigger number of uninsured patients, right? But hospitals show up and do that because they’re not going to turn people away. And those are the powerful messages that I think our lawmakers and policymakers need to hear from our folks on the ground.

SHAWN STACK

I think that’s a really good point, Beth, because sometimes I feel like, you know, academic medical centers, urban hospitals that really serve those outlying communities where the sickest and most severe patients are being transported to are many times overlooked for their capabilities and the staffing and the resources that they need to provide to the communities.

CHAD MULVANY

And we’ve thought about, you know, tert and quant services but when we think about the things that also in rural areas and other areas are closing, you know, it’s typically L&D, heavily paid for by Medicaid. And we have a maternal health crisis that is in part caused by the lack of access in these communities, because once you lose the OB services, you typically lose the OBGYNs that are providing the pre- and post-natal services.

The other piece on that, we obviously have a mental health crisis that fortunately we’ve recognized, but psych is also heavily paid for by Medicaid and Medicare. And so, kind of pointing those types of things out as well that the under reimbursement there is causing a direct issue in access to these two things that we as a society have determined we have issues with and we need to fix.

BETH FELDPUSH

Yeah, I, you know, access, I think one of the challenges that I always try to impress upon lawmakers and I don’t think I’m there yet, but people don’t disappear when services leave a community. So, people still have, still deliver babies. If those smaller hospitals are closing their labor and delivery departments, that means that other places are going to be more crowded.

I was speaking to a hospital recently and they were saying they’re a pretty small city in a very rural surrounding area. The average wait time as a new patient to see an OBGYN right now is 13 months.

SHAWN STACK

That doesn’t make sense.

CHAD MULVANY

No.

BETH FELDPUSH

So, you know, it’s just backups happen and emergency departments get crowded. People are traveling farther. People are delaying care, maybe because they don’t have coverage, or maybe because they can’t get in to see a doctor for 13 months. So, there’s impacts across every facet of the system and in every community when we see services contract at one or multiple providers.

CHAD MULVANY

Well, Beth, appreciate your time. This has certainly been an incredibly insightful conversation and certainly appreciate the calls to action that we wrapped up with. Certainly looking forward to having you on a future episode. And again, just want to thank you for your insights and your generosity with your time.

BETH FELDPUSH

Thank you all. Appreciate doing this with you and keep fighting the good fight.

SHAWN STACK

Beth, thanks again for joining us and sharing your perspective with our listeners. I’d also like to thank everyone for tuning in. You can follow “Achieving Health” on Apple Podcasts, Spotify, Amazon Music, or wherever you listen to podcasts. You can also now find us in the Health Podcast Library.

If you want to learn more about today’s topics we discussed here, be sure to check out the show notes for related content. You can also subscribe to our healthcare FORsights and follow us on LinkedIn to get regular insights and updates. And I welcome you to reach out to me, Chad, and the team here at Forvis Mazars if you have any questions about how these topics may affect your organization.

CHAD MULVANY

As a reminder, the podcast will be taking next week off, so Shawn and I will be back on Wednesday, December 2, for the next round of “Washington Watch” updates. Until then, here’s wishing everyone a Happy Thanksgiving. Certainly, as long as you don’t have a nut allergy, would encourage you to have that second slice of pecan pie, and also hope that you have good health for you and the communities you serve.

ANNOUNCER

You can follow “Achieving Health” on your favorite podcast platform or visit forvismazars.us/AchievingHealthPodcast to learn more.

“Achieving Health” is produced by Forvis Mazars LLP, an independent member of Forvis Mazars Global, a leading global professional services network. Ranked among the largest public accounting firms in the United States, the firm’s 7,000 dedicated team members provide an Unmatched Client Experience through the delivery of assurance, tax, and consulting services for clients in all 50 states and internationally through the global network.

The information set forth in this podcast contains the analysis and conclusions of the panelists based upon his, her, or their research and analysis of industry information and legal authorities. Such analysis and conclusions should not be deemed opinions or conclusions by Forvis Mazars or the panelists as to any individual situation as situations are fact specific.

The listener should perform their own analysis and form their own conclusions regarding any specific situation. Further, the panelists’ conclusions may be revised without notice, with or without changes in industry information and legal authorities.

Related FORsights

Like what you see?
Subscribe to receive tailored insights directly to your inbox.